Research methods to change clinical practice for patients with rare cancers
L Billingham, K Malottki, N Steven - The Lancet Oncology, 2016 - thelancet.com
Rare cancers are a growing group as a result of reclassification of common cancers by
molecular markers. There is therefore an increasing need to identify methods to assess …
molecular markers. There is therefore an increasing need to identify methods to assess …
Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system
Abstract Background The first consensus Merkel cell carcinoma (MCC) staging system was
published in 2010. New information on the clinical course prompts review of MCC staging …
published in 2010. New information on the clinical course prompts review of MCC staging …
Dramatic increase in the incidence and mortality from Merkel cell carcinoma in the United States
TL Fitzgerald, S Dennis, SD Kachare… - The American …, 2015 - journals.sagepub.com
Merkel cell carcinoma is a cutaneous neuroendocrine neoplasm that has been poorly
studied in contemporary cohorts. Patients with Merkel cell carcinoma from 1986 to 2011 …
studied in contemporary cohorts. Patients with Merkel cell carcinoma from 1986 to 2011 …
Recurrence and mortality risk of Merkel cell carcinoma by cancer stage and time from diagnosis
AM McEvoy, K Lachance, DS Hippe, K Cahill… - JAMA …, 2022 - jamanetwork.com
Importance Merkel cell carcinoma (MCC) often behaves aggressively; however, disease-
recurrence data are not captured in national databases, and it is unclear what proportion of …
recurrence data are not captured in national databases, and it is unclear what proportion of …
Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: a prospective validation study
BACKGROUND Merkel cell carcinoma (MCC) is an aggressive skin cancer with a
recurrence rate of> 40%. Of the 2000 MCC cases per year in the United States, most are …
recurrence rate of> 40%. Of the 2000 MCC cases per year in the United States, most are …
Virus-positive Merkel cell carcinoma is an independent prognostic group with distinct predictive biomarkers
Purpose: Merkel cell carcinoma (MCC) is an aggressive cutaneous neuroendocrine
carcinoma that can be divided into two classes: virus-positive (VP) MCC, associated with …
carcinoma that can be divided into two classes: virus-positive (VP) MCC, associated with …
Evidence-based medicine: cutaneous facial malignancies: nonmelanoma skin cancer
KL Connolly, KS Nehal, JJ Disa - Plastic and reconstructive …, 2017 - journals.lww.com
Skin malignancies are the most prevalent cancers, and plastic surgeons are often the
primary physicians engaged in diagnosis and management of these lesions. Proper …
primary physicians engaged in diagnosis and management of these lesions. Proper …
Merkel cell carcinoma: a population analysis on survival
V Sridharan, V Muralidhar, DN Margalit… - Journal of the National …, 2016 - jnccn.org
Purpose: Merkel cell carcinoma (MCC) is an aggressive cutaneous malignancy. However,
factors associated with disease presentation and outcomes remain uncertain, especially in …
factors associated with disease presentation and outcomes remain uncertain, especially in …
Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients
Background Merkel cell carcinoma (MCC) is a rare cutaneous malignancy of
neuroendocrine origin with a high propensity for lymph node metastasis. Sentinel lymph …
neuroendocrine origin with a high propensity for lymph node metastasis. Sentinel lymph …
[HTML][HTML] Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy
A Servy, E Maubec, PE Sugier, F Grange, S Mansard… - Annals of …, 2016 - Elsevier
Background Sentinel lymph-node (LN) biopsy (SLNB) is a valuable tool to assess the
regional LN status in Merkel cell carcinoma (MCC). However, its prognostic value is still …
regional LN status in Merkel cell carcinoma (MCC). However, its prognostic value is still …